Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › quercetin

quercetin

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of quercetin

4 trials tracked of quercetin.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3 Phase 1 1
  1. Phase 2 Quercetin in Coronary Artery By-pass Surgery Completed
  2. Phase 2 Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease Completed
  3. Phase 2 Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans Completed
  4. Phase 1 Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic Review: Flavonoids from Traditional Chinese Medicine Show Promise for NAFLD
Neurology Meta-analysis
Systematic Review: Flavonoids from Traditional Chinese Medicine Show Promise for NAFLD Flavonoids from Chinese medicine show promise for fatty liver disease
This systematic review examines flavonoids from traditional Chinese medicine for non-alcoholic fatty liver disease. The authors report that …
A systematic review suggests flavonoids from traditional Chinese medicine may improve liver health in humans and animals by reducing fat and…
Frontiers May 28, 2026
Narrative review examines antioxidant metabolites for autism spectrum disorder in children
Drug Pipeline Sys. Review
Narrative review examines antioxidant metabolites for autism spectrum disorder in children Could antioxidant nutrients help children with autism spectrum disorder?
This narrative review evaluates the potential role of antioxidant metabolites from botanical drugs and nutrients, including vitamins E and C…
Antioxidant nutrients like vitamins E and C, plus botanical compounds, may help address oxidative stress linked to autism spectrum disorder …
Frontiers Apr 19, 2026
Review of flavonoids shows preclinical neuroprotective potential in Parkinson's disease models
Drug Pipeline Sys. Review
Review of flavonoids shows preclinical neuroprotective potential in Parkinson's disease models Parkinson's drugs may need a new partner
This narrative review synthesizes preclinical evidence regarding flavonoids including baicalein, quercetin, apigenin, luteolin, and EGCG in …
Plant-based compounds could one day help treat Parkinson's by fixing multiple brain chemicals at once, not just dopamine.
Frontiers Apr 18, 2026
Review of quercetin in metabolic diseases shows promise but lacks clinical validation
Diabetes & Endocrinology RCT
Review of quercetin in metabolic diseases shows promise but lacks clinical validation Review suggests quercetin may have multiple beneficial effects on metabolic conditions
This review evaluates quercetin for conditions including diabetes, obesity, and gout.
A natural compound found in fruits and vegetables shows promise for managing type 2 diabetes, obesity, and fatty liver disease, though human…
Frontiers Apr 13, 2026
Dasatinib and Quercetin Show Promise in Improving Gait Speed in HIV-Associated Frailty
Infectious Disease Phase II
Dasatinib and Quercetin Show Promise in Improving Gait Speed in HIV-Associated Frailty Can a New Drug Combination Help Older Adults with HIV Regain Strength?
Phase II trial of dasatinib and quercetin (D+Q) in 82 HIV+ frail/prefrail adults shows potential in improving gait speed.
A new trial tests if two drugs help older adults with HIV regain strength and walk better after years of frailty.
CT.gov Mar 27, 2026